Tumor progression locus 2, a new potential prognostic factor and therapeutic target in activated B-cell-like diffuse large B-cell lymphoma

• Kota Yoshifuji,
• Yotaro Motomura,
• Makiko Saito,
• Genji Kawade,
• Shiori Watabe,
• Kouhei Yamamoto,
• Mai Soejima,
• Ayako Nogami,
• Satoru Aoyama,
• Takehiko Mori,
• Toshikage Nagao

Affiliations

Kota Yoshifuji

Department of Hematology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo

Yotaro Motomura

Department of Hematology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo

Makiko Saito

Department of Hematology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo

Genji Kawade

Department of Comprehensive Pathology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo

Shiori Watabe

Department of Comprehensive Pathology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo

Kouhei Yamamoto

Department of Comprehensive Pathology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo

Mai Soejima

Department of Hematology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo

Ayako Nogami

Department of Laboratory Medicine, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo

Satoru Aoyama

Department of Hematology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo

Takehiko Mori

Department of Hematology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo

Toshikage Nagao

Department of Hematology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo